Deerfield Management Company, L.P. (Series C) Absci Corp Transaction History
Deerfield Management Company, L.P. (Series C)
- $5.38 Billion
- Q3 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Absci Corp stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 265,382 shares of ABSI stock, worth $793,492. This represents 0.02% of its overall portfolio holdings.
Number of Shares
265,382
Previous 183,093
44.94%
Holding current value
$793,492
Previous $563,000
79.93%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ABSI
# of Institutions
128Shares Held
59.3MCall Options Held
255KPut Options Held
93.6K-
Redmile Group, LLC San Francisco, CA8.25MShares$24.7 Million2.06% of portfolio
-
Fred Alger Management, LLC New York, NY7.57MShares$22.6 Million0.15% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.34MShares$18.9 Million0.23% of portfolio
-
Black Rock Inc. New York, NY5.34MShares$16 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.94MShares$14.8 Million0.0% of portfolio
About Absci Corp
- Ticker ABSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 92,843,504
- Market Cap $278M
- Description
- Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....